Investigational drug tested for preventing muscle fiber death in muscular dystrophy

User rating: 4 / 5 after 1 vote(s)

An investigational antiviral drug currently undergoing human trials in Europe for treating Hepatitis C infections may have potential to reduce muscle cell damage in Duchenne and other forms of muscular dystrophy (MD). A research team led by Cincinnati Children’s Hospital Medical Center reported their results using three different mouse models of MD in a letter posted online March 16 by the journal Nature Medicine.


Full story »
All News summaries from Medicine & Health news
All News summaries for March 16, 2008

Flu vaccine not associated with reduced hospitalizations or outpatient visits among young children

5 hours ago | User rating: not rated yet
Use of the influenza vaccine was not associated with preventing hospitalizations or reducing physician visits for the flu in children age 5 and younger during two recent seasons, perhaps because the strains of virus in the ...

Individuals with social phobia see themselves differently

5 hours ago | User rating: not rated yet
Magnetic resonance brain imaging reveals that patients with generalized social phobia respond differently than others to negative comments about themselves, according to a report in the October issue of Archives of General ...

Occasional memory loss tied to lower brain volume

5 hours ago | User rating: not rated yet
People who occasionally forget an appointment or a friend's name may have a loss of brain volume, even though they don't have memory deficits on regular tests of memory or dementia, according to a study published in the October ...

Racial differences for brain bleeds suggest stroke risk greater than thought for blacks

5 hours ago | User rating: not rated yet
Small, clinically silent areas of bleeding in the brain appear to be more common in black versus white stroke patients hospitalized for new brain bleeds, say researchers at Georgetown University Medical Center. These findings ...

ADHD stimulant treatment may decrease risk of substance abuse in adolescent girls

5 hours ago | User rating: not rated yet
Massachusetts General Hospital (MGH) researchers have found that treatment with stimulant drugs does not increase and appears to significantly decrease the risk that girls with ADHD will begin smoking cigarettes or using ...
Goto Archive PhysOrg Forum Goto Archive Video Goto Archive Editorials Goto Archive Free Magazines Goto Archive Newsletter

News Archive